NCT01792323View on ClinicalTrials.gov

Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2014

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin LISPRO

Administration of 15 IU of insulin lispro over a period of 30 seconds

Trial Locations (1)

A-8036

Medical University of Graz, Graz

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Medical University of Graz

OTHER

NCT01792323 - Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations | Biotech Hunter | Biotech Hunter